| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/28/2005 | CN1672708A Dispersive tablet for treating heat-type stranguria and its prepn |
| 09/28/2005 | CN1672707A Cervicitis resisting dispersive tablet and its prepn |
| 09/28/2005 | CN1672706A Dispersive tablet of common lamiophlomis rhizome and its prepn |
| 09/28/2005 | CN1672705A Dispersive tablet of nudiflorus Taiwan beautyberry leaf and its prepn |
| 09/28/2005 | CN1672704A Erosion-eliminating effervescent tablet and its prepn |
| 09/28/2005 | CN1672703A Medicine xinqin tablet for treating allergic rhintis and its prepn |
| 09/28/2005 | CN1672702A Compound liver-nourishing ant tablet and bolus |
| 09/28/2005 | CN1672701A Chinese medicine capsule for treating women's dysmenorrhea |
| 09/28/2005 | CN1672700A External use medicine for treating facial paralysis peripherica and its prepn |
| 09/28/2005 | CN1672699A Medicine for treating phlebothrombosis and thrombotic superficial phlebitis of lower limb and its prepn |
| 09/28/2005 | CN1672697A Headache treating Chinese medicine |
| 09/28/2005 | CN1672696A Plaster for treating burns and scalds |
| 09/28/2005 | CN1672695A Medicine for treating apoplexy and its sequela |
| 09/28/2005 | CN1672692A Naoxuekang dripping pill and its prepn process |
| 09/28/2005 | CN1672690A Shengu dispersive tablet and its prepn process |
| 09/28/2005 | CN1672689A Nano silver antiseptic gel for treating women's genital tract infection and its prepn and application |
| 09/28/2005 | CN1672688A Medical composite chitinamine gel |
| 09/28/2005 | CN1672686A Dispersive asiaticoside tablet and its prepn process |
| 09/28/2005 | CN1672683A Hyperlipidemia treating composition |
| 09/28/2005 | CN1672682A Prepn containing fibrauretine microcapsule and its prepn process |
| 09/28/2005 | CN1672681A Moxixacin capsule and its prepn process |
| 09/28/2005 | CN1672680A Stable moxixacin tablet and its prepn process |
| 09/28/2005 | CN1672679A Application of externally applied phentolamine methane sulphonate prepn in treating female sexual apathy |
| 09/28/2005 | CN1672678A Separation and extraction of natural active long-chain fatty acid component for preventing and treating prostatosis and the prepn and application of its medicine prepn |
| 09/28/2005 | CN1672677A Grafted nano carbon and its suspension preparing process and medical use |
| 09/28/2005 | CN1672676A Clamped beriberi treating medicated cotton |
| 09/28/2005 | CN1220702C Insulinotropic peptide and its use |
| 09/28/2005 | CN1220517C Medication for curing disease of stomach intestine |
| 09/28/2005 | CN1220513C Chinese patent medicine for stopping blood, analgesia, removing blood stasis and engender new and its preparation method |
| 09/28/2005 | CN1220512C Capsule with pilose deerhorn blood and gingeng and its preparation method |
| 09/28/2005 | CN1220505C Freeze-dried garlic powder preparation and its preparation method |
| 09/28/2005 | CN1220504C Medicine for treating coronary heart disease and preparing method thereof |
| 09/28/2005 | CN1220500C Skin Chinese medicine disinfectant liquid and use in preparing medicine for suppressing prospermia |
| 09/28/2005 | CN1220496C Bougie for treating virus hepatitis and preparing method thereof |
| 09/28/2005 | CN1220494C Qiyeshenan drop pill for curing insomnia etc. |
| 09/28/2005 | CN1220489C Freeze-dried Danhong powder injection for injection and its preparing method |
| 09/28/2005 | CN1220485C Method for making coated granules with masked taste and instant release of active matter |
| 09/28/2005 | CN1220484C Microparticles for pulmonary administation |
| 09/28/2005 | CN1220483C Use of nanodispersions in pharmaceutical end formulations |
| 09/28/2005 | CN1220482C Medicine plaster production process utilizing hot melted glue |
| 09/28/2005 | CN1220451C 健康食品 Healthy Food |
| 09/27/2005 | US6950708 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening |
| 09/27/2005 | US6950707 Systems and methods for treatment of obesity and eating disorders by electrical brain stimulation and/or drug infusion |
| 09/27/2005 | US6949663 Multilayer; anticoagulant |
| 09/27/2005 | US6949575 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives |
| 09/27/2005 | US6949569 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 09/27/2005 | US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 09/27/2005 | US6949532 Use of mometasone furoate for treating airway passage and lung diseases |
| 09/27/2005 | US6949515 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases |
| 09/27/2005 | US6949509 Pharmaceutical composition containing a small or medium size peptide |
| 09/27/2005 | US6949504 Composition comprising at least one liquid fatty phase structured by at least one semi-crystalline polymer |
| 09/27/2005 | US6949264 Nutraceuticals or nutritional supplements and method of making |
| 09/27/2005 | US6949261 An isolate from the leaves of Gymnema sylvestre obtained by extracting Gymnema sylvestre leaves with aqueous ethanol, removing acid-insoluble salt from the extract, concentrating desalted extract, isolating an insulinotropically active principle |
| 09/27/2005 | US6949260 Administering Boswellia gum extract comprising at least 10% by weight of boswellic acids, and turmeric gum extract comprising at least about 30% by weight of curcuminoids. |
| 09/27/2005 | US6949259 Solid preparations for oral use |
| 09/27/2005 | US6949258 The invention is directed to an oral biological preparation for specific delivery in colon, especially an oral insulin preparation for specific delivery in colon. |
| 09/27/2005 | US6949257 Substance P antagonist; antidepressants; central nervous system disorders; respiratory system disorders |
| 09/27/2005 | US6949256 A film-forming composition comprising carrageenan, a bulking agent, plasticizer and water; encapsulating medicinal dosage forms, nutritional supplements, cosmetics, bath oils and gels, and paint balls |
| 09/27/2005 | US6949255 Especially HIV; applying a polyquaternium, glycerin, or a preservative system such as methylparaben or proplyparaben. |
| 09/27/2005 | US6949253 ultra-nanocrystalline diamond coated microchip drug delivery substrate that is impermeably sealed and inert for implantation in a living body |
| 09/27/2005 | US6949249 Mixture contains flow control agent and thickener |
| 09/27/2005 | US6949241 Use of lacrophyl preparation in eye drops containing therapeutically active compounds |
| 09/27/2005 | US6949218 Use of low molecular weight amino alcohols in ophthalmic compositions |
| 09/27/2005 | CA2428206C Methods for the treatment of cellular proliferative disorders |
| 09/27/2005 | CA2414271C Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
| 09/27/2005 | CA2164109C Molecular transdermal transport system |
| 09/27/2005 | CA2149120C Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 09/27/2005 | CA2122346C Bistriazenes as chemotherapeutic agents |
| 09/27/2005 | CA2079814C Cationic lipids for intracellular delivery of biologically active molecules |
| 09/27/2005 | CA2068970C Agent for transdermal administration containing ergoline derivatives |
| 09/23/2005 | CA2502169A1 Products and methods for treating vaginal infections |
| 09/22/2005 | WO2005087825A2 Temperature sensitive polymers |
| 09/22/2005 | WO2005087804A1 Erythropoietin liquid formulation |
| 09/22/2005 | WO2005087271A1 Compositions comprising cells and magnetic materials for targeted delivery |
| 09/22/2005 | WO2005087270A1 Anti-vaginitis compositions comprising a triazole |
| 09/22/2005 | WO2005087260A1 Co-encapsulated wt1 polypeptide and immunostimulant microsphere formulations and methods thereof |
| 09/22/2005 | WO2005087257A1 Remedy for repairing cartilage tissue having crosslinked gelatin gel as support |
| 09/22/2005 | WO2005087253A2 Interferon-beta for anti-virus therapy for respiratory diseases |
| 09/22/2005 | WO2005087242A1 Traditional chinese medicine preparation for cardio-cerebral blood vessel diseases and its preparing method |
| 09/22/2005 | WO2005087237A1 Fasudil-containing preparation and method of improving stability thereof |
| 09/22/2005 | WO2005087230A1 Solid pharmaceutical preparation containing sparingly water-soluble drug |
| 09/22/2005 | WO2005087221A1 Biodegradable biocompatible implant and method of manufacturing same |
| 09/22/2005 | WO2005087205A1 Process for producing medicine |
| 09/22/2005 | WO2005087204A1 Bioavailable solid dosage forms of metaxalone |
| 09/22/2005 | WO2005087203A1 Polymeric compositions and dosage forms comprising the same |
| 09/22/2005 | WO2005087202A1 Glucosamine polyacrylate inter-polymer complex and processes for their production |
| 09/22/2005 | WO2005087201A1 Hydrogel microspheres with improved release profile |
| 09/22/2005 | WO2005087200A1 Particulate plant sterol compositions |
| 09/22/2005 | WO2005087199A2 Stabilised supersaturated solid solutions of steroidal drugs |
| 09/22/2005 | WO2005087198A1 Processes for the preparation of solid dosage forms of amorphous valganciclovir hydrochloride |
| 09/22/2005 | WO2005087197A1 Enteric coating compositions |
| 09/22/2005 | WO2005087196A1 Drug delivery system based on immune response system |
| 09/22/2005 | WO2005087195A2 Novel compositions for topical delivery |
| 09/22/2005 | WO2005087194A1 Compositions comprising drospirenone molecularly dispersed |
| 09/22/2005 | WO2005087193A2 Chemoembolisation involving an anthracycline compound |
| 09/22/2005 | WO2005087192A2 Salmeterol inhalation formulations |
| 09/22/2005 | WO2005087182A1 Functional powders |
| 09/22/2005 | WO2005087016A1 Method of preparing a protein aggregate and a pharmaceutical composition |
| 09/22/2005 | WO2005086954A2 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 09/22/2005 | WO2005086915A2 Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor |